Search Within

Alexander Edward Drilon

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (76)
  2. Meeting Abstract (75)
  3. Research Letter (2)
  4. Book Section (1)
  5. Editorial (1)
  6. Guidelines (1)
Groups
  1. Department of Medicine (156)
  2. GSK Faculty (156)
  3. Human Oncology and Pathogenesis Program (156)
  4. Solid Tumor Oncology Division (156)
  5. Thoracic Oncology (156)
  6. Department of Pathology and Laboratory Medicine (150)

More Groups

People
  1. Marc Ladanyi (121)
  2. Maria Arcila (64)
  3. Mark Kris (54)
  4. Michael Berger (51)
  5. Charles Rudin (45)
  6. Gregory Riely (44)

More People

Years
  1. 2025 (2)
  2. 2024 (12)
  3. 2023 (9)
  4. 2022 (17)
  5. 2021 (14)
  6. 2020 (13)

More Years

Publications
  1. Journal of Clinical Oncology (33)
  2. Journal of Thoracic Oncology (19)
  3. Clinical Cancer Research (17)
  4. Cancer Research (9)
  5. JCO Precision Oncology (9)
  6. Cancer Discovery (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (43)
  2. American Association for Cancer Research (36)
  3. Elsevier Inc. (22)
  4. Nature Publishing Group (14)
  5. Oxford University Press (9)
  6. Elsevier Science, Inc. (8)

More Publishers

Results (156)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The prevalence of RET and ROS1 gene rearrangements in advanced lung adenocarcinomas pan-negative for other known drivers as revealed by FISH analysis
    Meeting Abstract

    Wang, L.; Islamdoust, N.; Drilon, A. E.; Rizvi, N.; Joubert, P.; Hasanovic, A.; Wynne, M.; Intrieri, J.; Jhanwar, S. C.; Ladanyi, M.
    Journal of Molecular Diagnostics (2013)

    Fulltext@MSK | Save
  • Response to cabozantinib in patients with RET fusion-positive lung adenocarcinomas
    Journal Article

    Drilon, A.; Wang, L.; Hasanovic, A.; Suehara, Y.; Lipson, D.; Stephens, P.; Ross, J.; Miller, V.; Ginsberg, M.; Zakowski, M. F.; more...
    Cancer Discovery (2013)

    Fulltext@MSK | Save
  • Comparison of the KRAS/EGFR mutation profile and survival of "collegiate smokers" and never smokers with advanced lung cancers
    Meeting Abstract

    Varghese, A. M.; Sima, C. S.; Chaft, J. E.; Johnson, M. L.; Janjigian, Y. Y.; Drilon, A. E. D.; Yu, H. A.; Riely, G. J.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • KIF5B-RET: Discovery of a novel fusion oncogene in lung adenocarcinomas by a systematic screen for tyrosine kinase fusions and identification of patients for a RET targeted therapy trial
    Meeting Abstract

    Suehara, Y.; Arcila, M. E.; Drilon, A. E. D.; Ito, T.; Wang, L.; Hasanovic, A.; Khanin, R.; Rizvi, N. A.; Ladanyi, M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions
    Journal Article

    Suehara, Y.; Arcila, M.; Wang, L.; Hasanovic, A.; Ang, D.; Ito, T.; Kimura, Y.; Drilon, A.; Guha, U.; Rusch, V.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Squamous-cell carcinomas of the lung: Emerging biology, controversies, and the promise of targeted therapy
    Journal Article

    Drilon, A.; Rekhtman, N.; Ladanyi, M.; Paik, P.
    Lancet Oncology (2012)

    Fulltext@MSK | Save